Converting patients intolerant of simvastatin to atorvastatin is a safe practice and associated with significant improvement in lipid control and less creatine kinase elevation
Publication
, Conference
Krasuski, RA; Doeppenschmidt, DL; Beck, RL; Henry, JS; Thompson, CM
Published in: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
March 19, 2003
Duke Scholars
Published In
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
ISSN
0735-1097
Publication Date
March 19, 2003
Volume
41
Issue
6
Start / End Page
245A / 245A
Location
CHICAGO, ILLINOIS
Publisher
ELSEVIER SCIENCE INC
Conference Name
52nd Annual Scientific Session of the American-College-of-Cardiology
Related Subject Headings
- Cardiovascular System & Hematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Krasuski, R. A., Doeppenschmidt, D. L., Beck, R. L., Henry, J. S., & Thompson, C. M. (2003). Converting patients intolerant of simvastatin to atorvastatin is a safe practice and associated with significant improvement in lipid control and less creatine kinase elevation. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (Vol. 41, pp. 245A-245A). CHICAGO, ILLINOIS: ELSEVIER SCIENCE INC.
Krasuski, R. A., D. L. Doeppenschmidt, R. L. Beck, J. S. Henry, and C. M. Thompson. “Converting patients intolerant of simvastatin to atorvastatin is a safe practice and associated with significant improvement in lipid control and less creatine kinase elevation.” In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 41:245A-245A. ELSEVIER SCIENCE INC, 2003.
Krasuski RA, Doeppenschmidt DL, Beck RL, Henry JS, Thompson CM. Converting patients intolerant of simvastatin to atorvastatin is a safe practice and associated with significant improvement in lipid control and less creatine kinase elevation. In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. ELSEVIER SCIENCE INC; 2003. p. 245A-245A.
Krasuski, R. A., et al. “Converting patients intolerant of simvastatin to atorvastatin is a safe practice and associated with significant improvement in lipid control and less creatine kinase elevation.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, vol. 41, no. 6, ELSEVIER SCIENCE INC, 2003, pp. 245A-245A.
Krasuski RA, Doeppenschmidt DL, Beck RL, Henry JS, Thompson CM. Converting patients intolerant of simvastatin to atorvastatin is a safe practice and associated with significant improvement in lipid control and less creatine kinase elevation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. ELSEVIER SCIENCE INC; 2003. p. 245A-245A.
Published In
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
ISSN
0735-1097
Publication Date
March 19, 2003
Volume
41
Issue
6
Start / End Page
245A / 245A
Location
CHICAGO, ILLINOIS
Publisher
ELSEVIER SCIENCE INC
Conference Name
52nd Annual Scientific Session of the American-College-of-Cardiology
Related Subject Headings
- Cardiovascular System & Hematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology